Fig. 8: MEG3-derived miR-493-5p overcomes the oncogenic feature of IGF2-miR-483 loss of imprinting in hepatic cancer cells.

Proposed regulatory network in which the rescue of epigenetically silenced miR-493-5p inhibits growth properties of liver cancer cells exhibiting IGF2-miR-483 LOI